Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis-Reference-Cited by-同舟云学术

Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis

Published:2007-01 Issue:1 Volume:24 Page:60-67
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Rhee Steven S.,Mah Francis S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02849993.pdf

Reference6 articles.

1. McCulley JP. Blepharoconjunctivitis.Int Ophthalmol Clin. 1984;24:65–77.

2. Leibowitz HM. The red eye.N Engl J Med. 2000;343:345–351.

3. Viswalingam M, Rauz S, Morlet N, Dart JKG. Blepharokeratoconjunctivitis in children: diagnosis and treatment.Br J Ophthalmol. 2005;89:400–403.

4. Hammersmith KM, Cohen EJ, Blake TD, Laibson PR, Rapuano CJ. Blepharokeratoconjunctivitis in children.Arch Ophthalmol. 2005;123:1667–1670.

5. Kuo A, Mah F. Evaluation of topical tobramycin/dexamethasone and tobramycin/loteprednol in the management of blepharokeratoconjunctivitis [abstract].Invest Ophthalmol Vis Sci. 2005; 46 (suppl 5):2673.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and comprehensive treatment of persistent corneal epithelial dysfunction after cataract surgery;BMC Ophthalmology;2024-04-26

2. Phenotypic and Transcriptomics Analyses Reveal Underlying Mechanisms in a Mouse Model of Corneal Bee Sting;Toxins;2022-07-08

3. Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis;Ophthalmology and Therapy;2021-10-27

4. Topical Steroids and Antibiotics for Adult Blepharokeratoconjunctivitis (BKC): A Meta-Analysis of Randomized Clinical Trials;Journal of Ophthalmology;2021-01-08

5. Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%;Journal of Ocular Pharmacology and Therapeutics;2019-06